ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
Position in GMED — Globus Medical Inc
CIK 1164508
BOSTON, MA
Position in GMED
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$78,655,894
+$40,149,565 QoQ
Shares Held
912,905
+107.0% QoQ
Ownership
0.673%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in GMED Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $3,649,670,055 across 35 Medical Devices names. GMED ranks #11 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
13,891,668 | $871,702,167 | |
| 2 | ABT |
Abbott Laboratories
|
5,522,222 | $566,966,532 | |
| 3 | SYK |
Stryker Corp
|
1,555,638 | $511,167,090 | |
| 4 | MDT |
Medtronic plc
|
4,659,425 | $403,739,176 | |
| 5 | PODD |
Insulet Corp
|
1,229,928 | $258,088,091 | |
| 6 | DXCM |
Dexcom Inc
|
2,545,103 | $159,832,468 | |
| 7 | EW |
Edwards Lifesciences Corp
|
1,890,859 | $151,419,988 | |
| 8 | PEN |
Penumbra Inc
|
400,160 | $131,400,539 |
All Filings in GMED
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $78,655,894 | 912,905 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $38,506,329 | 441,030 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $12,333,323 | 215,354 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $6,106,504 | 103,465 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $5,639,035 | 77,036 | Shares | Defined | 2025-05-14 | |
| 2023-09-30 | $12,850,363 | 258,819 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $10,882,244 | 182,772 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $9,626,477 | 169,959 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $551,603 | 7,427 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,879,137 | 48,332 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $503,688 | 8,972 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,268,144 | 30,742 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $10,547,698 | 146,090 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $19,399,111 | 253,186 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $10,664,096 | 137,548 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $6,041,748 | 97,969 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $8,265,917 | 126,739 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $16,319,415 | 329,552 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $7,454,448 | 156,245 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $6,694,604 | 157,409 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||